Offer An Article

Pandemic Latest News

Alzheimer’s disease

Example of an Ebola treatment unit

New data reveals Ebola vaccine reduces mortality by half; The latest health stories from around the world

There’s welcome news in the battle against the Ebola virus, an infectious disease that for years had almost no treatments or remedies.  Outbreaks of the deadly Ebola virus flare up in parts of Africa almost every year, and they’re vicious.  The virus kills about half the people it infects. But a new study published in The …

New data reveals Ebola vaccine reduces mortality by half; The latest health stories from around the world Read More »

Nobel Prize awarded for COVID-19 mRNA vaccine development; The latest health stories from around the world

The 2023 Nobel Prize in Physiology or Medicine has been jointly awarded to Katalin Karikó and Drew Weissman for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19 https://www.nobelprize.org/prizes/medicine/2023/press-release/  The discoveries by the two Nobel Laureates were critical for developing effective mRNA vaccines against COVID-19 during the pandemic …

Nobel Prize awarded for COVID-19 mRNA vaccine development; The latest health stories from around the world Read More »

US Senate approves budget increase for biomedical research; The latest health stories from around the world

To the relief of biomedical research advocates, a US Senate spending panel has approved a modest budget increase of 2% for the National Institutes of Health (NIH). The bump to $47.8 billion roughly matches President Joe Biden’s request for the 2024 fiscal year that begins this fall. Although below the rate of biomedical inflation, it …

US Senate approves budget increase for biomedical research; The latest health stories from around the world Read More »

More affordable tuberculosis medication on the horizon; The latest health stories from around the world

The pharmaceutical company Johnson & Johnson (J&J) in mid-July agreed to help make a therapy critical to fighting drug-resistant tuberculosis (TB) more widely available and affordable. J&J said it would allow competitors to market generic versions of the lifesaving drug, bedaquiline, in 44 low- and middle-income countries (LMICs) where the company has active patents. www.science.org/content/article/news-glance-ben-franklin-s-anticounterfeiting-science-s-english-language-barrier? …

More affordable tuberculosis medication on the horizon; The latest health stories from around the world Read More »

Malaria vaccine to be trialled across Africa; The latest health stories from around the world

Twelve countries across different regions in Africa are set to receive 18 million doses of the first-ever malaria vaccine over the next two years. The roll out is a critical step forward in the fight against one of the leading causes of death in the continent. www.gavi.org/news/media-room/18-million-doses-first-ever-malaria-vaccine-allocated-12-african-countries-2023 The allocations have been determined through the application …

Malaria vaccine to be trialled across Africa; The latest health stories from around the world Read More »

Alzheimer's disease

Indian study finds potential new Alzheimer’s disease biomarker

Initial test results from studies conducted in India may have uncovered potential biomarkers that could be used as an early detection tool in diagnosing individuals with early-stage Alzheimer’s disease.  A group of researchers led by professor Pravat Mandal at the National Brain Research Centre (NBRC) in Manesar, Gurgaon have found a statistically significant correlation of …

Indian study finds potential new Alzheimer’s disease biomarker Read More »

Approval of Alzheimer’s drug “rife with irregularities”

US drug regulators failed to follow their own guidance and practices when they approved the controversial Alzheimer’s drug Aduhelm, a congressional report said on Thursday. www.theguardian.com/us-news/2022/dec/29/biogen-fda-alzheimers-aduhelm-congressional-report? The US food and drug administration’s (FDA) process of approval, it said, had been “rife with irregularities”, and the FDA’s interactions with maker Biogen had been “atypical”. The report …

Approval of Alzheimer’s drug “rife with irregularities” Read More »

Potential new therapy for Alzheimer’s disease

In a packed San Francisco conference room last Tuesday, upbeat company representatives and scientists presented detailed clinical trial data on the first Alzheimer’s treatment shown to clearly, albeit modestly, slow the disease’s normal cognitive decline. The antibody therapy has buoyed a field marked by decades of failures. Now, it appears to be on the cusp …

Potential new therapy for Alzheimer’s disease Read More »

New COVID-19 strain poses serious reinfection risk; The latest health stories from around the world

Health experts across the globe are signalling alarm as they begin reporting that Omicron BA.5, the coronavirus strain that is currently outpacing other variants in infection and has become the dominant strain in the United States (US) and abroad, has the ability to reinfect people within weeks of contracting the virus. Andrew Robertson, the chief …

New COVID-19 strain poses serious reinfection risk; The latest health stories from around the world Read More »

Air pollution and dementia, an ominous link

According to an elongated study conducted at the University of Washington, air pollution raises the risks of dementia, lending fears that the bulk of India’s population could be rendered far more prone to developing the condition. The study used data from two long running datasets — one that began in the late 1970s charting air …

Air pollution and dementia, an ominous link Read More »